Pictured is a cholesterol-filled atherosclerotic coronary artery from a human body. Researchers at the University of Pennsylvania School of Medicine have demonstrated the potential of a new type of therapy for patients who suffer from high cholesterol levels. A new study shows that targeted inhibition of the microsomal triglyceride transfer protein (MTP) is highly effective in reducing cholesterol levels in very high risk patients.

Image Courtesy: University of Pennsylvania School of Medicine

Download high-resolution version (510 KB, JPG, 300 DPI)